Roberto Peschechera
Papers
2
Total Citations
51
H-Index
2
About
Roberto Peschechera is a urologic surgeon and researcher whose work centers on improving outcomes for prostate cancer patients, particularly through the refinement of surgical techniques and predictive tools. His major contributions lie in two key areas: enhancing the accuracy of postoperative prognosis and optimizing recovery protocols. In a pivotal 2015 study, he demonstrated that the preoperative Prostate Health Index (PHI) is an independent predictor of early biochemical recurrence after radical prostatectomy, a finding that has garnered 26 citations and offers clinicians a valuable biomarker for risk stratification. Building on this, his 2018 Ripreca Study, a prospective randomized trial with 25 citations, provided robust evidence that early catheter removal after robot-assisted radical prostatectomy is safe and feasible, significantly improving patient comfort and reducing recovery time without compromising outcomes. These studies, both from a single-institutional prospective design, underscore Peschechera’s commitment to evidence-based practice and patient-centered care. His work has directly influenced perioperative management in robotic urologic surgery, making him a notable contributor to the field’s evolution toward less invasive, more personalized treatment pathways.
Research Focus
Key Achievements
Top Papers
- 1
- 2